Immediate Impact

1 from Science/Nature 48 standout
Sub-graph 1 of 20

Citing Papers

An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases
2024 Standout
2 intermediate papers

Works of Katherine Labella being referenced

Development of Selective Covalent Janus Kinase 3 Inhibitors
2015

Author Peers

Author Last Decade Papers Cites
Katherine Labella 64 14 68 33 5 137
Iris Leung 94 4 97 40 5 225
Joshua A. Ballard 145 22 47 47 6 244
Ruth E. Feltell 130 65 104 20 6 232
Adriana Zupa-Fernandez 42 2 57 22 3 105
О. В. Головенко 84 15 39 7 4 164
Brian Juba 40 5 51 17 4 130
Sachie Otsuki 136 26 75 12 5 224
Pawan Bir Kohli 83 1 112 61 3 194
Ifra Mushtaq 120 31 80 15 6 238
Bruce Bank 72 27 54 29 7 129

All Works

Loading papers...

Rankless by CCL
2026